Assistant Professor Shanta Dhar has been granted a three-year Idea development Award from the Department of Defense Congressionally Directed Prostate Cancer Research Program (DoD-PCRP) for her grant entitled, “Combined Chemotherapy and Anti-Inflammatory Therapy for Metastatic Castration-Resistant Prostate Cancer (CRPC) using a Nanoparticle Platform.” This study aims to develop a targeted combination therapeutic approach for the treatment for metastatic prostate cancer using a highly engineered nanoparticle. The project, which focuses on prostate cancer, can be applied to other cancers as well. Successful completion of these studies will open up new treatment options for patients with prostate cancer. The Department of Defense awarded $28.8 million in grants through the PCRP Idea award this year. UGA joined other leading institutes receiving one such grant. Shanta Dhar is one of only 59 scientists to win the DoD Idea award from 519 applications this year.
